Oscillating immunoassay method and device

• US 9,329,175 B2
• Filed: 08/05/2011
• Issued: 05/03/2016
• Est. Priority Date: 08/05/2010
• Status: Active Grant

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Miller, Cary James, Campbell, John Lewis Emerson
• Primary Examiner(s): Shibuya, Mark
• Assistant Examiner(s): DO, PENSEE T
• Application Number:
  US13/204,172
• Publication Number:
  US 20120034624A1
• Time in Patent Office: 1,733 Days
• Field of Search: 436/526, 436/518
• US Class Current: 1/1
• CPC Class Codes: G01N 33/54333 Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Abstract

The present invention provides apparatus and methods for the rapid determination of analytes in liquid samples by immunoassays incorporating magnetic capture of beads on a sensor capable of being used in the point-of-care diagnostic field.

Claims

1. A magnetic immunosensing device for detecting an analyte in a sample, comprising:

a dry reagent comprising magnetically susceptible beads, wherein the dry reagent is present in the device as a coating on a sample entry port, a sample entry chamber, a sensing device or a conduit and further wherein the beads are coated with an antibody to the analyte in the sample;

a sensing electrode on a substantially planar chip, wherein the electrode is positioned in a conduit for receiving the sample containing the analyte mixed with the beads;

two magnetic zones positioned in the conduit; and

an oscillating device for applying an oscillating magnetic field across the surface of the electrode to move the beads back and forth across the surface to attract the beads in the conduit substantially proximate to the electrode and to substantially retain the beads at the electrode surface;

wherein said immunosensing device is adapted for receiving the sample and wherein the oscillating magnetic field oscillates in the direction of a capture motion of the beads.

2. The device of claim 1, wherein the beads comprise ferrite.

3. The device of claim 1, wherein the beads comprise magnetite (Fe₃O₄).

4. The device of claim 1, wherein the beads comprise a magnetically susceptible core with a polymer coating.

5. The device of claim 1, wherein the beads have an average particle size of from 0.01 μ

m to 20 μ

m.

6. The device of claim 1, wherein the beads have an average particle size of from 0.1 μ

m to 5 μ

m.

7. The device of claim 1, wherein the beads have an average particle size of from 0.2 μ

m to 1.5 μ

m.

8. The device of claim 1, wherein the antibody is to a low-abundance analyte in the sample.

9. The device of claim 1, wherein the antibody is to an analyte selected from the group consisting of cardiac troponin I, troponin T, a troponin complex, human chorionic gonadotropin, BNP, creatine kinase, creatine kinase subunit M, creatine kinase subunit B, creatine kinase MB (CK-MB), proBNP, NT-proBNP, myoglobin, myosin light chain and modified fragments thereof.

10. The device of claim 1, wherein the antibody is to an analyte selected from the group consisting of beta-HCG, TSH, ultra hTSH II, TT3, TT4, FT3, FT4, myeloperoxidase, D-dimer, CRP, NGAL, PSA, LH, FSH, prolactin, progesterone, estradiol, DHEA-S, AFP, CA 125 II, CA 125, CA 15-3, CA 19-9, CA 19-9XR, CEA, thyroxine (T4), triiodothyronine (T3), T-uptake, Tg, anti-Tg, anti-TPO, ferritin, cortisol, insulin, HBsAg, HCV Ag/Ab combo, HCV core Ag, anti-HCV, AUSAB (anti-HBs), CORE, CORE-M, SHBG, iPTH, theophylline, sirolimus, tacrolimus, anti-HAV, anti-HAV IgM, HAVAB, HAVAB-M, HAVAB-M2.0, HAVAB-G, HAVAB 2.0, HAVAB 2.0 Quant, IgM, CMV IgM, CMV IgG, â

-2-microglobulin, digitoxin, HBe, anti-HBe, HBeAg, HIV 1/2gO, HIV Ag/Ab combo, testosterone, SCC, vitamin B12, folate, syphilis, anti-HBc, rubella IgG, rubella IgM, homocysteine, MPO, cytomegalovirus (CMV) IgG Avidity, toxo IgG avidity, toxo IgG, toxo IgM, C-peptide, vitamin D, HTLV I/II, total â

hCG, progesterone, estradrogen, prolactin, myoglobin, tPSA, fPSA, carbamazepine (CBZ), digoxin, gentamicin, NAPA, phenytoin, phenobarbital, valproic acid, vancomycin, procaine, quinidine, tobramycin, methamphetamine (METH), amphetamine (AMPH), barbiturates, benzodiazepine, cannabis, cocaine, methadone, opiates, PCP, acetaminophen, ethanol, salicylates, tricyclics, holoTc, anti-CCP, HbA1c, barbs-U and modified fragments thereof.

11. The device of claim 1, wherein the oscillating device comprises a coil.

12. The device of claim 1, wherein the oscillating device comprises a fixed magnet on a mobile platform.

13. The device of claim 1, wherein the electrode is microfabricated.

14. The device of claim 1, wherein the electrode is amperometric.

15. The device of claim 1, wherein the electrode is a gold microarray.

16. The device of claim 1, wherein the conduit has a height of about 0.2 mm to about 5 mm and a width of about 0.2 mm to about 5 mm.

17. The device of claim 1, wherein the conduit has a uniform cross-sectional area.

18. The device of claim 1, wherein the conduit has a non-uniform cross-sectional area.

19. The device of claim 1, further comprising a reference sensor.

20. The device of claim 1, further comprising one or more differently-labeled magnetically susceptible beads.

21. The device of claim 1, further comprising a second sensing electrode.